Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport(®)) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?

por Huynh Le Maux, Amélie, Pignol, Bernadette, Behr-Roussel, Delphine, Blachon, Jean-Luc, Chabrier, Pierre-Etienne, Compagnie, Sandrine, Picaut, Philippe, Bernabé, Jacques, Giuliano, François, Denys, Pierre
Publicado 2015

Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors

por Tao, Liang, Peng, Lisheng, Berntsson, Ronnie P.-A., Liu, Sai Man, Park, SunHyun, Yu, Feifan, Boone, Christopher, Palan, Shilpa, Beard, Matthew, Chabrier, Pierre-Etienne, Stenmark, Pål, Krupp, Johannes, Dong, Min
Publicado 2017

IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates

por Aron Badin, Romina, Spinnewyn, Brigitte, Gaillard, Marie-Claude, Jan, Caroline, Malgorn, Carole, Van Camp, Nadja, Dollé, Frédéric, Guillermier, Martine, Boulet, Sabrina, Bertrand, Anne, Savasta, Marc, Auguet, Michel, Brouillet, Emmanuel, Chabrier, Pierre-Etienne, Hantraye, Philippe
Publicado 2013

Correction: IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates

por Aron Badin, Romina, Spinnewyn, Brigitte, Gaillard, Marie-Claude, Jan, Caroline, Malgorn, Carole, Van Camp, Nadja, Dollé, Frédéric, Guillermier, Martine, Boulet, Sabrina, Bertrand, Anne, Savasta, Marc, Auguet, Michel, Brouillet, Emmanuel, Chabrier, Pierre-Etienne, Hantraye, Philippe
Publicado 2013

High-throughput 3D whole-brain quantitative histopathology in rodents

por Vandenberghe, Michel E., Hérard, Anne-Sophie, Souedet, Nicolas, Sadouni, Elmahdi, Santin, Mathieu D., Briet, Dominique, Carré, Denis, Schulz, Jocelyne, Hantraye, Philippe, Chabrier, Pierre-Etienne, Rooney, Thomas, Debeir, Thomas, Blanchard, Véronique, Pradier, Laurent, Dhenain, Marc, Delzescaux, Thierry
Publicado 2016